BACKGROUND: Early acute kidney injury (AKI) following trauma is associated with multiorgan failure and mortality. Leukotrienes have been implicated both in AKI and in acute lung injury. Activated 5-lipoxygenase (5-LO) colocalizes with 5-LO-activating protein (FLAP) in the first step of leukotriene production following trauma and hemorrhagic shock (T/HS). Diversion of postshock mesenteric lymph, which is rich in the 5-LO substrate of arachidonate, attenuates lung injury and decreases 5-LO/FLAP associations in the lung after T/HS. We hypothesized that mesenteric lymph diversion (MLD) will also attenuate postshock 5-LO-mediated AKI. METHODS: Rats underwent T/HS (laparotomy, hemorrhagic shock to a mean arterial pressure of 30 mm Hg for 45 minutes, and resuscitation), and MLD was accomplished via cannulation of the mesenteric duct. Extent of kidney injury was determined via histology score and verified by urinary neutrophil gelatinase-associated lipocalin assay. Kidney sections were immunostained for 5-LO and FLAP, and colocalization was determined by fluorescence resonance energy transfer signal intensity. The end leukotriene products of 5-LO were determined in urine. RESULTS: AKI was evident in the T/HS group by derangement in kidney tubule architecture and confirmed by neutrophil gelatinase-associated lipocalin assay, whereas MLD during T/HS preserved renal tubule morphology at a sham level. MLD during T/HS decreased the associations between 5-LO and FLAP demonstrated by fluorescence resonance energy transfer microscopy and decreased leukotriene production in urine. CONCLUSION: 5-LO and FLAP colocalize in the interstitium of the renal medulla following T/HS. MLD attenuates this phenomenon, which coincides with pathologic changes seen in tubules during kidney injury and biochemical evidence of AKI. These data suggest that gut-derived leukotriene substrate predisposes the kidney and the lung to subsequent injury.
BACKGROUND: Early acute kidney injury (AKI) following trauma is associated with multiorgan failure and mortality. Leukotrienes have been implicated both in AKI and in acute lung injury. Activated 5-lipoxygenase (5-LO) colocalizes with 5-LO-activating protein (FLAP) in the first step of leukotriene production following trauma and hemorrhagic shock (T/HS). Diversion of postshock mesenteric lymph, which is rich in the 5-LO substrate of arachidonate, attenuates lung injury and decreases 5-LO/FLAP associations in the lung after T/HS. We hypothesized that mesenteric lymph diversion (MLD) will also attenuate postshock 5-LO-mediated AKI. METHODS:Rats underwent T/HS (laparotomy, hemorrhagic shock to a mean arterial pressure of 30 mm Hg for 45 minutes, and resuscitation), and MLD was accomplished via cannulation of the mesenteric duct. Extent of kidney injury was determined via histology score and verified by urinary neutrophil gelatinase-associated lipocalin assay. Kidney sections were immunostained for 5-LO and FLAP, and colocalization was determined by fluorescence resonance energy transfer signal intensity. The end leukotriene products of 5-LO were determined in urine. RESULTS: AKI was evident in the T/HS group by derangement in kidney tubule architecture and confirmed by neutrophil gelatinase-associated lipocalin assay, whereas MLD during T/HS preserved renal tubule morphology at a sham level. MLD during T/HS decreased the associations between 5-LO and FLAP demonstrated by fluorescence resonance energy transfer microscopy and decreased leukotriene production in urine. CONCLUSION:5-LO and FLAP colocalize in the interstitium of the renal medulla following T/HS. MLD attenuates this phenomenon, which coincides with pathologic changes seen in tubules during kidney injury and biochemical evidence of AKI. These data suggest that gut-derived leukotriene substrate predisposes the kidney and the lung to subsequent injury.
Authors: Max V Wohlauer; Angela Sauaia; Ernest E Moore; Clay Cothren Burlew; Anirban Banerjee; Jeffrey Johnson Journal: J Trauma Acute Care Surg Date: 2012-02 Impact factor: 3.313
Authors: Christoph Thiemermann; Nimesh S A Patel; Espen O Kvale; Gillian W Cockerill; Paul A J Brown; Keith N Stewart; Salvatore Cuzzocrea; Domenico Britti; Helder Mota-Filipe; Prabal K Chatterjee Journal: J Am Soc Nephrol Date: 2003-07 Impact factor: 10.121
Authors: Alaa S Awad; Michael Rouse; Liping Huang; Amy L Vergis; Jörg Reutershan; Helen P Cathro; Joel Linden; Mark D Okusa Journal: Kidney Int Date: 2009-01-07 Impact factor: 10.612
Authors: Hunter B Moore; Ernest E Moore; Peter J Lawson; Eduardo Gonzalez; Miguel Fragoso; Alex P Morton; Fabia Gamboni; Michael P Chapman; Angela Sauaia; Anirban Banerjee; Christopher C Silliman Journal: Surgery Date: 2015-06-05 Impact factor: 3.982
Authors: Anne L Slaughter; Angelo D'Alessandro; Ernest E Moore; Anirban Banerjee; Christopher C Silliman; Kirk C Hansen; Julie A Reisz; Miguel Fragoso; Matthew J Wither; Anthony W Bacon; Hunter B Moore; Erik D Peltz Journal: J Trauma Acute Care Surg Date: 2016-12 Impact factor: 3.313
Authors: Jeniann Yi; Anne Slaughter; Cassandra V Kotter; Ernest E Moore; Carl J Hauser; Kiyoshi Itagaki; Max Wohlauer; Daniel N Frank; Christopher Silliman; Anirban Banerjee; Erik Peltz Journal: Shock Date: 2015-10 Impact factor: 3.454
Authors: Patrick F Walker; Anthony D Foster; Philip A Rothberg; Thomas A Davis; Matthew J Bradley Journal: PLoS One Date: 2018-11-29 Impact factor: 3.240